Join us at the 30th annual ESGCT—European Society of Gene & Cell Therapy—in Brussels on 24-27 October.
Visit us at Booth #117 to experience the future of CRISPR genome editing! Explore our complete design-to-analysis workflow solutions that are crafted to empower your CRISPR genome editing research. These solutions save you time and increase your efficiency.
Rolf Turk, PhD., is a Senior Manager of Genomic Medicine at IDT. Rolf is originally from the Netherlands, where he obtained a Master’s degree in Science at the University of Amsterdam. He continued his training as a graduate student at the Center for Human and Clinical Genetics at the Leiden University Medical Center. His research revolved around the molecular mechanisms behind different forms of muscular dystrophy. After obtaining his PhD, he continued his research as a post-doctoral researcher at the University of Iowa. Since joining IDT in 2015, Rolf has contributed to the development of RNA-guided endonucleases and the optimization of delivery strategies. Additionally, he focuses on off-target nomination and validation methodologies.
Rolf Turk, PhD, will present his poster, Large knock-in in primary T cells with optimized Cas9 HDR methods and design, which provides insight into honing homology-directed repair experiments in primary T cells.